DLK Investment Management’s Quest Diagnostics DGX Stock Holding History

DLK Investment Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$718K	Hold	5,248	–	–	0.31%	47
2026 Q1	$1.03M	Hold	5,248	–	–	0.41%	40
2025 Q4	$911K	Hold	5,248	–	–	0.34%	44
2025 Q3	$1M	Hold	5,248	–	–	0.38%	42
2025 Q2	$943K	Hold	5,248	–	–	0.36%	43
2025 Q1	$888K	Hold	5,248	–	–	0.37%	41
2024 Q4	$792K	Hold	5,248	–	–	0.33%	43
2024 Q3	$815K	Hold	5,248	–	–	0.31%	46
2024 Q2	$718K	Buy	5,248 +100	+2%	+$13.7K	0.3%	48
2024 Q1	$685K	Buy	5,148 +70	+1%	+$9.08K	0.29%	45
2023 Q4	$700K	Buy	+5,078	New	+$668K	0.32%	45

Other funds holding DGX

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BCAM

Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLK Investment Management's DGX Position: Q2 2026 in Review

DLK Investment Management held its Quest Diagnostics (DGX) position steady in Q2 2026 at 5,248 shares worth $718K. The position accounts for 0.31% of the portfolio, ranked #47.

DLK Investment Management first reported a position in DGX in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.03M in Q1 2026. 266 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

DLK Investment Management held 5,248 shares of Quest Diagnostics worth $718K as of Q2 2026.
DLK Investment Management left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up 0.31% of DLK Investment Management's portfolio in Q2 2026, its #47 holding.
DLK Investment Management first reported a position in Quest Diagnostics in Q4 2023 and has held it in 11 quarters since.
DLK Investment Management's Quest Diagnostics position peaked at $1.03M in Q1 2026.
266 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on DLK Investment Management's 13F filing for Q2 2026, filed 14 Jul 2026.